Mint Tower Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,400
Closed -$2.21M 296
2022
Q4
$2.21M Sell
8,400
-2,800
-25% -$751K 0.2% 91
2022
Q3
$2.52M Sell
11,200
-6,200
-36% -$1.5M 0.2% 114
2022
Q2
$4.23M Hold
17,400
0.34% 57
2022
Q1
$4.21M Buy
+17,400
New +$4M 0.39% 41
2020
Q2
Sell
-11,400
Closed -$2.31M 257
2020
Q1
$2.31M Sell
11,400
-2,000
-15% -$437K 0.44% 46
2019
Q4
$3.23M Buy
13,400
+9,900
+283% +$2.18M 0.43% 61
2019
Q3
$677K Buy
+3,500
New +$672K 0.1% 129
2019
Q1
Sell
-100
Closed -$1.95M 186
2018
Q4
$1.95M Sell
100
-9,900
-99% -$1.93M 0.25% 84
2018
Q3
$2.07M Sell
10,000
-10,000
-50% -$1.97M 0.26% 82
2018
Q2
$3.69M Hold
20,000
0.49% 51
2018
Q1
$3.41M Buy
+20,000
New +$3.67M 0.46% 37

Other funds holding AMGN

Mint Tower Capital Management's AMGN Position: Q1 2023 in Review

Mint Tower Capital Management sold out of Amgen (AMGN) in Q1 2023, closing a stake of 1,458 shares — an estimated $383K sold.

Mint Tower Capital Management first reported a position in AMGN in Q1 2018 and held it in 4 quarters. The position peaked at $1M in Q3 2022. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Mint Tower Capital Management reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Mint Tower Capital Management sold 1,458 Amgen shares in Q1 2023, an estimated $383K.
  • Mint Tower Capital Management first reported a position in Amgen in Q1 2018 and held it in 4 quarters.
  • Mint Tower Capital Management's Amgen position peaked at $1M in Q3 2022.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Mint Tower Capital Management's 13F filing for Q1 2023, filed 9 May 2023.